Target Binding Site Detail
Target General Information | Top | ||||
---|---|---|---|---|---|
Target ID | T59328 | Target Info | |||
Target Name | Epidermal growth factor receptor (EGFR) | ||||
Synonyms | Receptor tyrosine-protein kinase erbB-1; Proto-oncogene c-ErbB-1; HER1; ERBB1; ERBB | ||||
Target Type | Successful Target | ||||
Gene Name | EGFR | ||||
Biochemical Class | Kinase | ||||
UniProt ID |
Ligand General Information | Top | ||||
---|---|---|---|---|---|
Ligand Name | 6-(2-chloranyl-3-fluoranyl-phenyl)-5-methyl-2-[[3-methyl-4-(4-methylpiperazin-1-yl)phenyl]amino]-8-[(3S)-1-propanoylpiperidin-3-yl]pyrido[2,3-d]pyrimidin-7-one | Ligand Info | |||
Canonical SMILES | CCC(=O)N1CCCC(C1)N2C3=NC(=NC=C3C(=C(C2=O)C4=C(C(=CC=C4)F)Cl)C)NC5=CC(=C(C=C5)N6CCN(CC6)C)C | ||||
InChI | 1S/C34H39ClFN7O2/c1-5-29(44)42-13-7-8-24(20-42)43-32-26(22(3)30(33(43)45)25-9-6-10-27(36)31(25)35)19-37-34(39-32)38-23-11-12-28(21(2)18-23)41-16-14-40(4)15-17-41/h6,9-12,18-19,24H,5,7-8,13-17,20H2,1-4H3,(H,37,38,39)/t24-/m0/s1 | ||||
InChIKey | REZLHNFSSBBSFC-DEOSSOPVSA-N | ||||
PubChem Compound ID | 137436802 |
Drug Binding Sites of Target | Top | |||||
---|---|---|---|---|---|---|
PDB ID: 6JRK The structure of co-crystals of 8r-B-EGFR WT complex | ||||||
Method | X-ray diffraction | Resolution | 2.80 Å | Mutation | Yes | [1] |
PDB Sequence |
GEAPNQALLR
705 ILKETEFKKI715 KVLGSGAFGT725 VYKGLWIPEG735 EKVKIPVAIK745 ELNKEILDEA 763 YVMASVDNPH773 VCRLLGICLT783 STVQLITQLM793 PFGCLLDYVR803 EHKDNIGSQY 813 LLNWCVQIAK823 GMNYLEDRRL833 VHRDLAARNV843 LVKTPQHVKI853 TDFGLAKVPI 878 KWMALESILH888 RIYTHQSDVW898 SYGVTVWELM908 TFGSKPYDGI918 PASEISSILE 928 KGERLPQPPI938 CTIDVYMIMV948 KCWMIDADSR958 PKFRELIIEF968 SKMARDPQRY 978 LVIQGDERME1005 DMDDVVDADE1015 YLI
|
|||||
|
LEU718
3.709
GLY719
3.547
VAL726
4.044
ALA743
3.693
ILE744
4.728
LYS745
3.498
GLU762
3.447
MET766
3.270
CYS775
3.961
LEU788
3.315
THR790
2.879
|
|||||
PDB ID: 6JRJ The structure of co-crystals of 8r-B-EGFR T790M/C797S complex | ||||||
Method | X-ray diffraction | Resolution | 2.94 Å | Mutation | Yes | [1] |
PDB Sequence |
GEAPNQALLR
705 ILKETEFKKI715 KVLGSGAFGT725 VYKGLWIPEG735 EKVKIPVAIK745 ELSPKANKEI 759 LDEAYVMASV769 DNPHVCRLLG779 ICLTSTVQLI789 MQLMPFGSLL799 DYVREHKDNI 809 GSQYLLNWCV819 QIAKGMNYLE829 DRRLVHRDLA839 ARNVLVKTPQ849 HVKITDFGLA 859 KLPIKWMALE884 SILHRIYTHQ894 SDVWSYGVTV904 WELMTFGSKP914 YDGIPASEIS 924 SILEKGERLP934 QPPICTIDVY944 MIMVKCWMID954 ADSRPKFREL964 IIEFSKMARD 974 PQRYLVIQGD984 ERMHLPMDDV1010 VDADEYLI
|
|||||
|
LEU718
3.682
GLY719
3.920
VAL726
4.110
ALA743
3.751
ILE744
4.677
LYS745
3.449
GLU762
3.410
MET766
4.455
CYS775
3.843
LEU788
3.762
MET790
3.480
GLN791
3.579
|
References | Top | ||||
---|---|---|---|---|---|
REF 1 | Structure-Based Design of 5-Methylpyrimidopyridone Derivatives as New Wild-Type Sparing Inhibitors of the Epidermal Growth Factor Receptor Triple Mutant (EGFR(L858R/T790M/C797S)). J Med Chem. 2019 Aug 8;62(15):7302-7308. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.